These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12518029)

  • 1. Brain lipid metabolism in the cPLA2 knockout mouse.
    Rosenberger TA; Villacreses NE; Contreras MA; Bonventre JV; Rapoport SI
    J Lipid Res; 2003 Jan; 44(1):109-17. PubMed ID: 12518029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment.
    Chang MC; Bell JM; Purdon AD; Chikhale EG; Grange E
    Neurochem Res; 1999 Mar; 24(3):399-406. PubMed ID: 10215514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain arachidonic acid incorporation and precursor pool specific activity during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat.
    Washizaki K; Smith QR; Rapoport SI; Purdon AD
    J Neurochem; 1994 Aug; 63(2):727-36. PubMed ID: 8035197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manoalide, a phospholipase A2 inhibitor, inhibits arachidonate incorporation and turnover in brain phospholipids of the awake rat.
    Grange E; Rabin O; Bell J; Chang MC
    Neurochem Res; 1998 Oct; 23(10):1251-7. PubMed ID: 9804280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of two intracellular phospholipase A2s in fatty acid release in the cell death pathway. Proteolytic fragment of type IVA cytosolic phospholipase A2alpha inhibits stimulus-induced arachidonate release, whereas that of type VI Ca2+-independent phospholipase A2 augments spontaneous fatty acid release.
    Atsumi G; Murakami M; Kojima K; Hadano A; Tajima M; Kudo I
    J Biol Chem; 2000 Jun; 275(24):18248-58. PubMed ID: 10747887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies.
    Yu W; Bozza PT; Tzizik DM; Gray JP; Cassara J; Dvorak AM; Weller PF
    Am J Pathol; 1998 Mar; 152(3):759-69. PubMed ID: 9502418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of brain polyunsaturated fatty acid uptake and turnover.
    Chen CT; Green JT; Orr SK; Bazinet RP
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):85-91. PubMed ID: 18938067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers.
    Chang MC; Contreras MA; Rosenberger TA; Rintala JJ; Bell JM; Rapoport SI
    J Neurochem; 2001 May; 77(3):796-803. PubMed ID: 11331408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the role of group VI phospholipase A2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells.
    Ramanadham S; Hsu FF; Bohrer A; Ma Z; Turk J
    J Biol Chem; 1999 May; 274(20):13915-27. PubMed ID: 10318801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrospray ionization/mass spectrometric analyses of human promonocytic U937 cell glycerolipids and evidence that differentiation is associated with membrane lipid composition changes that facilitate phospholipase A2 activation.
    Hsu FF; Ma Z; Wohltmann M; Bohrer A; Nowatzke W; Ramanadham S; Turk J
    J Biol Chem; 2000 Jun; 275(22):16579-89. PubMed ID: 10748096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonate release and prostaglandin production by group IVC phospholipase A2 (cytosolic phospholipase A2gamma).
    Murakami M; Masuda S; Kudo I
    Biochem J; 2003 Jun; 372(Pt 3):695-702. PubMed ID: 12611587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.
    Ramadan E; Chang L; Chen M; Ma K; Hall FS; Uhl GR; Rapoport SI; Basselin M
    Int J Neurosci; 2012 Jul; 122(7):373-80. PubMed ID: 22376027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)β)-knockout mice.
    Cheon Y; Kim HW; Igarashi M; Modi HR; Chang L; Ma K; Greenstein D; Wohltmann M; Turk J; Rapoport SI; Taha AY
    Biochim Biophys Acta; 2012 Sep; 1821(9):1278-86. PubMed ID: 22349267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s.
    Kita Y; Ohto T; Uozumi N; Shimizu T
    Biochim Biophys Acta; 2006 Nov; 1761(11):1317-22. PubMed ID: 16962823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity.
    Rubin BB; Downey GP; Koh A; Degousee N; Ghomashchi F; Nallan L; Stefanski E; Harkin DW; Sun C; Smart BP; Lindsay TF; Cherepanov V; Vachon E; Kelvin D; Sadilek M; Brown GE; Yaffe MB; Plumb J; Grinstein S; Glogauer M; Gelb MH
    J Biol Chem; 2005 Mar; 280(9):7519-29. PubMed ID: 15475363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of phospholipid metabolism, proliferation, and secretion of stably transfected insulinoma cells that overexpress group VIA phospholipase A2.
    Ma Z; Bohrer A; Wohltmann M; Ramanadham S; Hsu FF; Turk J
    Lipids; 2001 Jul; 36(7):689-700. PubMed ID: 11521967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen peroxide-induced arachidonic acid release in L929 cells; roles of Src, protein kinase C and cytosolic phospholipase A2alpha.
    Taniguchi T; Shimizu M; Nakamura H; Hirabayashi T; Fujino H; Murayama T
    Eur J Pharmacol; 2006 Sep; 546(1-3):1-10. PubMed ID: 16914136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproyl-CoA and esterified valproic acid are not found in brains of rats treated with valproic acid, but the brain concentrations of CoA and acetyl-CoA are altered.
    Deutsch J; Rapoport SI; Rosenberger TA
    Neurochem Res; 2003 Jun; 28(6):861-6. PubMed ID: 12718439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling.
    Rapoport SI
    J Mol Neurosci; 2001; 16(2-3):243-61; discussion 279-84. PubMed ID: 11478380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.